⌘K

Login Start Free

Home/Filings/4/0001415889-25-023553

4//SEC Filing

Ragosa Mark 4

Accession 0001415889-25-023553

CIK 0001730430other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:45 PM ET

Size

26.1 KB

Accession

0001415889-25-023553

Insider Transaction Report

Form 4

Period: 2025-09-01

Kiniksa Pharmaceuticals International, plcKNSA

CHIEF FINANCIAL OFFICER

Transactions

Exercise/Conversion
Class A Ordinary Share
2025-09-01+1,592→ 28,601 total
Exercise/Conversion
Class A Ordinary Share
2025-09-01+1,750→ 30,351 total
Tax Payment
Class A Ordinary Share
2025-09-01$33.49/sh−2,920$97,791→ 30,125 total
Tax Payment
Class A Ordinary Share
2025-09-02$34.28/sh−900$30,852→ 31,086 total
Exercise/Conversion
Restricted Share Unit
2025-09-01−1,592→ 4,773 total
→ Class A Ordinary Share (1,592 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-01−2,694→ 2,694 total
→ Class A Ordinary Share (2,694 underlying)
Award
Restricted Share Unit
2025-09-01+12,275→ 12,275 total
→ Class A Ordinary Share (12,275 underlying)
Award
Share Option
2025-09-01+39,363→ 39,363 total
Exercise: $33.49Exp: 2035-08-31→ Class A Ordinary Share (39,363 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-01−1,750→ 3,500 total
→ Class A Ordinary Share (1,750 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-02−1,861→ 0 total
→ Class A Ordinary Share (1,861 underlying)
Exercise/Conversion
Class A Ordinary Share
2025-09-01+2,694→ 33,045 total
Exercise/Conversion
Class A Ordinary Share
2025-09-02+1,861→ 31,986 total

Footnotes (7)

[F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
[F2]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2025.
[F3]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025.
[F4]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
[F5]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
[F6]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
[F7]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.

Documents

1 file

4
form4-09032025_080932.xmlPrimary

Issuer

Kiniksa Pharmaceuticals International, plc

CIK 0001730430

Entity typeother

Related Parties

1

filerCIK 0001835458

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 4:45 PM ET
Size: 26.1 KB

View on SEC.gov